Evidence map›Paper›PMID 42512335›Full record

ReviewCancers2026

Impact of Adding Immune Checkpoint Inhibitors to Neoadjuvant Chemotherapy on pCR and Tumor Downstaging in Resectable Gastric Cancer: A Meta-Analysis.

Mariam Grazia Polito, Luisana Sisca, Davide Caruso, Antonella Cosimati, Federica Lo Prinzi, Carla Adriana Ramirez Reinaga, Etien Leka, Daniele Santini, Gian Paolo Spinelli

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mariam Grazia PolitoUOC Oncologia Territoriale, ASL Latina, CDS Aprilia, La Sapienza Università Di Roma Polo Pontino, 04100 Latina, Italy.ORCID 0000-0002-1586-8676
Luisana SiscaDepartment of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy.ORCID 0009-0001-1414-529X
Davide CarusoUOC Oncologia Territoriale, ASL Latina, CDS Aprilia, La Sapienza Università Di Roma Polo Pontino, 04100 Latina, Italy.
Antonella CosimatiUOC Oncologia Territoriale, ASL Latina, CDS Aprilia, La Sapienza Università Di Roma Polo Pontino, 04100 Latina, Italy.ORCID 0000-0002-2636-3198
Federica Lo PrinziOncologia, Presidio Ospedaliero Umberto I, 00161 Siracusa, Italy.ORCID 0000-0002-0408-5721
Carla Adriana Ramirez ReinagaUOC Oncologia Territoriale, ASL Latina, CDS Aprilia, La Sapienza Università Di Roma Polo Pontino, 04100 Latina, Italy.
Etien LekaUOC Oncologia Territoriale, ASL Latina, CDS Aprilia, La Sapienza Università Di Roma Polo Pontino, 04100 Latina, Italy.ORCID 0009-0006-0903-9421
Daniele SantiniDepartment of Medical and Surgical Science and Biotechnology, Università "La Sapienza", 04100 Rome, Italy.
Gian Paolo SpinelliUOC Oncologia Territoriale, ASL Latina, CDS Aprilia, La Sapienza Università Di Roma Polo Pontino, 04100 Latina, Italy.ORCID 0000-0002-4363-6274

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

gastric cancerimmune checkpoint inhibitors (ICIs)pathological complete responseperioperative chemo-immunotherapy

Identifiers

PMID42512335
PMCPMC13406764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.